Fenwick partners Alan Smith and Katherine Duncan hosted a virtual roundtable, a confidential session for TechGC members focused on high-level board matter considerations. Jolie Siegel, Chief Legal Officer at C4 Therapeutics led the discussion.
Topics included how a company should think about its board, how that changes over the life cycle of the company, the size of its board and composition, when to consider public company board composition, corporate governance at the board level, and leveraging outside counsel.
The next roundtable will be held in November as part of the Global Summit.